Elanco Animal Health Inc. (NYSE:ELAN) Q4 2022 Results Conference Call February 21, 2023 8:00 AM ET

Company Participants

Katy Grissom - Head of Investor Relations

Jeff Simmons - President and Chief Executive Officer

Todd Young - Chief Financial Officer

Conference Call Participants

Michael Ryskin - Bank of America

Erin Wright - Morgan Stanley

Chris Schott - JPMorgan

Umer Raffat - Evercore ISI

Jon Block - Stifel

Elliot Wilbur - Raymond James

Balaji Prasad - Barclays

Brandon Vazquez - William Blair

Operator

Good morning, and welcome to Elanco Animal Health's Fourth Quarter and Full Year 2022 Earnings Call. All participants are in a listen-only mode. After the speakers presentation we will conduct the question and answer session. [Operator Instructions] As a reminder, this conference is being recorded.

I would now like to turn the call over to Katy Grissom, Head of Investor Relations. Thank you. Please go ahead.

Katy Grissom

Good morning. Thank you for joining us for Elanco Animal Health's fourth quarter and full year 2022 earnings call. I'm Katy Grissom, Head of Investor Relations. Joining me on today's call are Jeff Simmons, our President and Chief Executive Officer; Todd Young, our Chief Financial Officer; and Scott Purucker from Investor Relations.

The slides referenced during this call are available on the Investor Relations section of elanco.com. Today's discussion will include forward-looking statements. These statements are based on our current assumptions, and expectations and are subject to risks and uncertainties that could cause actual results to differ materially from our forecast. For more information, see the risk factors discussed in today's earnings press release, as well as our latest Form 10-K and 10-Q filed with the SEC. We do not undertake any duty to update any forward-looking statements.

Our remarks today will focus on our non-GAAP financial measures. Reconciliations of these non-GAAP measures are included in the appendix of today's slides and in the earnings press release. After our prepared remarks, we'll be happy to take your questions.

I will now turn the call over to Jeff.

Jeff Simmons

Thanks, Katy. Good morning, everyone. Reflecting on our 4 years since completing our IPO, I am proud of and grateful for the determination and dedication of the Elanco team. We have fully separated and established an independent company. We've integrated the industry's largest acquisition, reset our cost base and built a strong leadership team.

In 2022, we continue to execute our IPP strategy, significantly advancing our innovation pipeline while driving productivity gains across all areas of the company and positioning the business for acceleration in 2024 and beyond. In 2022, our financial results were negatively impacted beyond our expectations due to significant challenging macro factors and competitive innovation. However, we are encouraged as we look forward, as shown on Slide 4.